Could a pacemaker also treat high blood pressure? a new device aims to do both.

NCT ID NCT03757377

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial tests a special pacemaker called the Moderato System in people who need a pacemaker and have high blood pressure that is hard to control with medication. The device is implanted like a regular pacemaker and may help lower blood pressure by adjusting the heart's pacing. About 200 participants will be randomly assigned to have the blood-pressure-lowering feature turned on or off for 12 months, while continuing their usual blood pressure drugs. The study measures whether the device safely reduces average blood pressure over 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
BackBeat Moderato System (implantable device)
What this could lead to
If it works, this device could offer a new way to control blood pressure without extra drugs for people who already need a pacemaker.
What could go wrong
This is a mid-stage trial with 203 participants. The device is implanted and carries surgical risks, and the blood-pressure benefit may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIOVENTRICULAR BLOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Samodzielnym Publicznym Centralnym Szpitalem Klinicznym

    Warsaw, 02-097, Poland

  • Silesian Center for Heart Diseases

    Zabrze, 41-800, Poland

  • UZ Brussel - Heart Rhythm Management Center

    Brussels, 1090, Belgium

  • Vilnius University Hospital Santariskiu Klinikos

    Vilnius, 08661, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.